Helmut Beckmann

Helmut Beckmann's AcademicInfluence.com Rankings

Helmut Beckmann

Psychology

#3505

World Rank

#3952

Historical Rank

Clinical Psychology

#333

World Rank

#338

Historical Rank

psychology Degrees

Helmut Beckmann

Philosophy

#8913

World Rank

#12387

Historical Rank

Logic

#5922

World Rank

#7380

Historical Rank

philosophy Degrees

Download Badge

Psychology
Philosophy

Why Is Helmut Beckmann Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Helmut Beckmann's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. (1999) (615)
Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain (2005) (525)
Prenatal developmental disturbances in the limbic allocortex in schizophrenics (2005) (276)
Antidepressant response to tricyclics and urinary MHPG in unipolar patients. Clinical response to imipramine or amitriptyline. (1975) (249)
Splitting schizophrenia: periodic catatonia-susceptibility locus on chromosome 15q15. (2000) (190)
[The serotonin hypothesis of depression]. (1990) (183)
Hippocampal neuron number in schizophrenia. A stereological study. (1991) (181)
Decreased Catalase Activity but Unchanged Superoxide Dismutase Activity in Brains of Patients with Dementia of Alzheimer Type (1995) (174)
Systematic mutation screening and association study of the A1 and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of disease (1998) (164)
Cortex, white matter, and basal ganglia in schizophrenia: A volumetric postmortem study (1991) (154)
Limbic structures and lateral ventricle in schizophrenia. A quantitative postmortem study. (1990) (133)
Vasopressin-oxytocin in cerebrospinal fluid of schizophrenic patients and normal controls (1985) (130)
Parkinson’s disease and depression: evidence for an alteration of the basal limbic system detected by transcranial sonography (1997) (120)
Different genetic background of schizophrenia spectrum psychoses: a twin study. (1998) (119)
Systematic search for variation in the human norepinephrine transporter gene: identification of five naturally occurring missense mutations and study of association with major psychiatric disorders. (1996) (118)
Reduced echogenicity of brainstem raphe specific to unipolar depression: A transcranial color-coded real-time sonography study (1995) (109)
Echogenicity of substantia nigra determined by transcranial ultrasound correlates with severity of parkinsonian symptoms induced by neuroleptic therapy (2001) (107)
Genetic heterogeneity in catatonic schizophrenia : A family study (1996) (99)
(3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients (2005) (96)
Confirmation of reduced temporal limbic structure volume on magnetic resonance imaging in male patients with schizophrenia (1996) (95)
Gross and Histological Criteria for Developmental Disorders in Brains of Schizophrenics (1989) (95)
Demonstration of monoamine oxidase-A and -B in the human brainstem by a histochemical technique (1989) (84)
Urinary MHPG in subgroups of depressed patients and normal controls. (1980) (84)
Differences in P300 amplitudes and topography between cycloid psychosis and schizophrenia in Leonhard's classification (1993) (77)
Morphometric studies of the entorhinal cortex in neuropsychiatric patients and controls: clusters of heterotopically displaced lamina II neurons are not indicative of schizophrenia Schizophrenia Research 33 (1998) 125–132 (2002) (75)
Altered distribution of parvalbumin-immunoreactive local circuit neurons in the anterior cingulate cortex of schizophrenic patients (1997) (69)
Multidimensional analysis of the concentrations of 17 substances in the CSF of schizophrenics and controls (1985) (68)
First‐trimester maternal gestational infection and cycloid psychosis (1997) (68)
Periodic catatonia: confirmation of linkage to chromosome 15 and further evidence for genetic heterogeneity (2002) (65)
Platelet MAO activity and personality characteristics (1981) (64)
The anticholinergic biperiden in depressive disorders. (1981) (64)
Ontogenesis of monoamine oxidase-A and -B in the human brain frontal cortex (1989) (61)
Corticotropin and Cortisol Response to Human CRH as a probe for HPA system integrity in major depressive disorder (1988) (60)
CSF monoamine metabolites in schizophrenic patients (1982) (60)
Specific P300 features in patients with cycloid psychosis (1996) (59)
The human striatum in schizophrenia. II. Increased number of striatal neurons in schizophrenics (1997) (58)
Prognostic Validity of the Cycloid Psychoses (1990) (58)
Neurotensin-like immunoreactivity in cerebrospinal fluid of patients with schizophrenia, depression, anorexia nervosa-bulimia, and premenstrual syndrome. (1989) (57)
Increased volume of the nucleus accumbens in schizophrenia (2001) (57)
Dexamethasone suppression test in a pluri‐diagnostic approach: its relationship to psychopathological and clinical variables (1983) (56)
Alzheimer’s Disease. Epidemiology, Neuropathology, Neurochemistry, and Clinics (1990) (56)
Growth hormone (GH) response to GH-releasing hormone in depression. (1987) (55)
Circumscribed malformation and nerve cell alterations in the entorhinal cortex of schizophrenics (1994) (55)
Dopamine and noradrenalin in the cerebrospinal fluid of schizophrenic patients (1983) (54)
Blunted adrenocorticotropin but normal beta-endorphin release after human corticotropin-releasing hormone administration in depression. (1989) (53)
Variations of monoamines and their metabolites in the human brain putamen (1992) (51)
Season-of-birth effect reveals the existence of etiologically different groups of schizophrenia (1992) (47)
On interrater reliability for Leonhard's classification of endogenous psychoses. (1997) (46)
HLA antigens and schizophrenia: A pool of two studies (1981) (46)
Periodic catatonia: A schizophrenic subtype with major gene effect and anticipation (2005) (46)
Is computerized tomography ventricular abnormality related to cycloid psychosis? (1996) (46)
Long-Term Course and Outcome of Severe Postpartum Psychiatric Disorders (1999) (45)
Catecholamine metabolism under sleep deprivation therapy of improved and not improved depressed patients. Contributions to biochemistry. (1974) (44)
The role of maternal infectious diseases during pregnancy in the etiology of schizophrenia in offspring (1992) (44)
Increased frequency of dentate granule cells with basal dendrites in the hippocampal formation of schizophrenics (2003) (44)
3H-spiperone binding sites in post-mortem brains from schizophrenic patients: Relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms (2005) (44)
Neuronal nicotinic acetylcholine receptor alpha 4 subunit (CHRNA4) and panic disorder: an association study. (1997) (43)
Pimozide versus Haloperidol in acute schizophrenia. A double blind controlled study. (1982) (43)
Cycloid psychoses predominate in severe postpartum psychiatric disorders. (1998) (43)
MRI findings in medial temporal lobe structures in schizophrenia (1990) (43)
Prenatal disturbances of nerve cell migration in the entorhinal region: a common vulnerability factor in functional psychoses? (2005) (42)
Developmental malformations in cerebral structures of schizophrenic patients (1999) (41)
Short CAG repeats within the hSKCa3 gene associated with schizophrenia: results of a family‐based study (1998) (41)
Puerperal and Cycloid Psychoses (1990) (41)
Low CSF Concentrations of Cyclic GMP in Schizophrenia (1983) (40)
Lack of association between schizophrenia and alleles of the dopamine D1, D2, D3 and D4 receptor loci1 (1993) (39)
Linkage and family-based association study of schizophrenia and the synapsin III locus that maps to chromosome 22q13. (2000) (39)
Susceptibility of Brains from Patients with Alzheimer's Disease to Oxygen-Stimulated Lipid Peroxidation and Differential Scanning Calorimetry (1992) (39)
Postpartum psychoses: Prognosis, risk factors, and treatment (2002) (39)
Identification of benzodiazepines in Artemisia dracunculus and Solanum tuberosum rationalizing their endogenous formation in plant tissue. (2000) (38)
Disturbed glucocorticoid receptor autoregulation and corticotropin response to dexamethasone in depressives pretreated with metyrapone (1991) (38)
Schizophrenias in the Wernicke-Kleist-Leonhard school. (2000) (37)
Gene-environment interaction in schizophrenia: season-of-birth effect reveals etiologically different subgroups. (1996) (37)
Should Plasma or Urinary MHPG be Measured in Psychiatric Research? A Critical Comment (1986) (36)
The human striatum in schizophrenia. I. Increase in overall relative striatal volume in schizophrenics (1997) (36)
Naturally occurring benzodiazepines: current status of research and clinical implications (2000) (34)
Low angiotensin-converting enzyme activity (kininase II) in cerebrospinal fluid of schizophrenics. (1984) (33)
Novel 5'-regulatory region polymorphisms of the 5-HT2C receptor gene: association study with panic disorder. (2000) (33)
Growth hormone (GH) responses to GH-releasing hormone in depression: Correlation with GH release following clonidine (1988) (32)
Cycloid Psychoses and Their Differentiation from Affective and Schizophrenic Psychoses (2001) (31)
Pathochemical Markers in Major Psychoses (1985) (31)
hKCNN3 which maps to chromosome 1q21 is not the causative gene in periodic catatonia, a familial subtype of schizophrenia (2000) (30)
Glutamate in schizophrenics and healthy controls (2004) (29)
A double‐blind multicentre study comparing remoxipride, two and three times daily, with haloperidol in schizophrenia (1990) (28)
Insulin‐like growth factor I in depressed patients and controls (1988) (28)
Disturbed neural circuits in a subtype of chronic catatonic schizophrenia demonstrated by F-18-FDG-PET and F-18-DOPA-PET (2001) (28)
Cycloid psychoses are not part of a bipolar affective spectrum: results of a controlled family study. (2004) (28)
Norepinephrine transporter gene (NET) variants in patients with panic disorder (2002) (28)
Deficit of birthrates in winter and spring months in distinct subgroups of mainly genetically determined schizophrenia. (1992) (28)
Antipsychotic efficacy of clozapine in correlation to changes in catecholamine metabolism in man. (1974) (27)
Exposure to prenatal infections, genetics and the risk of systematic and periodic catatonia (2002) (27)
The influence of neuroleptics on specific syndromes and symptoms in schizophrenics with unfavourable long-term course. A 5-year follow-up study of 50 chronic schizophrenics. (1992) (26)
Attenuated growth hormone response to growth hormone-releasing hormone in major depressive disorder (1987) (25)
Inhibitory cartridge synapses in the anterior cingulate cortex of schizophrenics (1999) (25)
Polymorphic MAO-A and 5-HT-Transporter Genes: Analysis of Interactions in Panic Disorder (2000) (24)
Schizophrenia : not a disease entity? A study of 57 long-term hospitalized chronic schizophrenics (1992) (23)
Melatonin immunoreactivity in cerebrospinal fluid of schizophrenic patients and healthy controls (1984) (23)
The effect of neuroleptic treatment and of high dosage diazepam therapy onβ-endorphin immunoreactivity in plasma of schizophrenic patients (2005) (22)
[Genetic heterogeneity of schizophrenia. Results of a systematic twin study]. (1996) (22)
[Cranial computed tomography in schizophrenia research]. (1981) (22)
Altered P300 topography due to functional and structural disturbances in the limbic system in dementia and psychoses and to pharmacological conditions (1989) (22)
Urinary excretion of 3-methoxy-4-hydroxyphenylglycol in depressed patients: modifications by amphetamine and lithium. (1976) (21)
Parent‐of‐origin effect and evidence for differential transmission in periodic catatonia (1998) (21)
Functional PAX-6 gene-linked polymorphic region: potential association with paranoid schizophrenia (1999) (21)
Granule cells of the dentate gyrus with basal and recurrent dendrites in schizophrenic patients and controls. A comparative Golgi study (2003) (20)
Memantine inhibits [3H]MK-801 binding to human hippocampal NMDA receptors. (1994) (20)
Growth hormone (GH) and prolactin responses after GH-releasing hormone in major depressive disorder: Relationship to somatomedin C levels and dexamethasone suppressibility of cortisol (1988) (19)
Guidelines for the dosage of antipsychotic drugs (1990) (19)
Morphometry of the parahippocampal gyrus in schizophrenics and controls. Some anatomical considerations (2005) (19)
[Pregnancy infections in mothers of chronic schizophrenic patients. The significance of differential nosology]. (1994) (19)
Cortical layer I changes in schizophrenia: a marker for impaired brain development? (2005) (18)
Exonic variants of the GABAB receptor gene and panic disorder (2000) (18)
Abnormal responsiveness of growth hormone to human corticotropin-releasing hormone in major depressive disorder. (1988) (18)
The cholinergic agonist RS 86: a pharmacopsychological study. (1988) (18)
Gender Differences and Age of Onset in the Catatonic Subtypes of Schizophrenia (1998) (18)
Dexamethasone suppression test combined with total sleep deprivation in depressed patients. (1983) (18)
Baclofen (para-chlorphenyl-GABA) in schizophrenia. (1977) (18)
Prognostic validity of the cycloid psychoses. A prospective follow-up study. (1990) (17)
HLA ANTIGENS AND SCHIZOPHRENIA (1980) (17)
Delta sleep-inducing peptide response to human corticotropin-releasing hormone (CRH) in major depressive disorder Comparison with CRH-Induced corticotropin and cortisol secretion (1988) (17)
Trazodone and amitriptyline in treatment of depressed inpatients. A double-blind study. (1981) (17)
[Benzodiazepine therapy: an evaluation]. (1984) (17)
Low platelet MAO activity and schizophrenia: sex differences (1981) (17)
[Prenatal developmental disorders of brain structures in schizophrenic psychoses]. (1994) (16)
Dexamethasone Suppression Test Predicts Response to Nomifensine Or Amitriptyline (1984) (16)
The Role of Dopamine in the Control of Neurobiological Functions (1989) (16)
Adenosine A1 receptors in human hippocampus: inhibition of [3H]8-cyclopentyl-1,3-dipropylxanthine binding by antagonist drugs (1993) (15)
Clinical and biochemical effects of the selective phosphodiesterase inhibitor rolipram in depressed inpatients controlled by determination of plasma level. (1988) (15)
[Proceedings: D-Amphetamine in manic syndrome (author's transl)]. (1976) (15)
High dose diazepam in schizophrenia (2004) (15)
Adenosine A1 receptor and bipolar affective disorder: systematic screening of the gene and association studies. (1998) (15)
Sex Differences and Distinct Subgroups in Schizophrenia (1992) (15)
The Role of Brain Dopamine (1989) (15)
Excitotoxins l-β-oxalyl-amino-alanine (l-BOAA) and 3, 4, 6-trihydroxyphenylalanine (6-OH-DOPA) inhibit [3H]α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) binding in human hippocampus (1994) (15)
A null mutation allele in the CNTF gene and schizophrenic psychoses. (1996) (15)
Multidimensional analysis of the concentrations of 17 substances in the CSF of schizophrenics and controls (2002) (15)
Moclobemide and maprotiline in the treatment of inpatients with major depressive disorder. (1989) (15)
Lymphocyte glucocorticoid receptor binding during depression and after clinical recovery. (1991) (14)
Plasma moclobemide and metabolites: lack of correlation with clinical response and biogenic amines (2004) (14)
A possible association between HLA B-27 and vulnerability to schizophrenia (1985) (14)
Haloperidol increases the cerebrospinal fluid concentrations of cyclic GMP in schizophrenic patients. (1984) (14)
Puerperal and cycloid psychoses. Results of a retrospective study. (1990) (14)
[Pharmacological treatment of affective disorders (author's transl)]. (1981) (14)
CNTF and endogenous psychoses? (1996) (14)
[Biochemical basis of endogenous depression (author's transl)]. (1978) (14)
Analgesic and euphoric effects of high dose diazepam in schizophrenia. (1982) (14)
Phenelzine in Depressed Patients (1977) (14)
Disturbances of Corticogenesis in Schizophrenia: Morphological Findings Provide New Evidence for the Maldevelopmental Hypothesis (1999) (13)
The neuropathology of schizophrenia (1982) (13)
dl-Phenylalanine versus imipramine: A double-blind controlled study (1979) (13)
Effect of moderate exercise on urinary MHPG in depressed patients. (1979) (13)
Regional differences in the interaction of the excitotoxins domoate and L-β-oxalyl-amino-alanine with [3H]kainate binding sites in human hippocampus (1995) (13)
Specific P300 features in patients with cycloid psychosis (1997) (13)
Dl-phenylalanine in depressed patients: An open study (2005) (13)
Clinical, biochemical and psychometric findings with the new MAO-A-inhibitors moclobemide and brofaromine in patients with major depressive disorder. (1990) (12)
Characterization of Glucocorticoid Binding Capacity in Human Mononuclear Lymphocytes: Increase by Metyrapone is Prevented by Dexamethasone Pretreatment (1990) (12)
Laminar neuropathology in Alzheimer's disease by a modified Gallyas impregnation (1989) (12)
Pathophysiology of delirious states. (1978) (12)
[Syndrome and symptom development in long-term follow-up of schizophrenia]. (1991) (11)
Diurnal changes in dopamine-β-hydroxylase, homovanillic acid and 3-methoxy-4-hydroxyphenylglycol in serum of man (2005) (11)
Association between a null mutation in the human ciliary neurotrophic factor (CNTF) gene and increased of psychiatric diseases? (1996) (11)
Guidelines for biological Treatment of Schizophrenia, : Part 1: Acute Treatment of Schizophrenia and Part 2: Long-term Treatment of Schizophrenia (2005) (11)
Brain quinolinic acid in Alzheimer's dementia (2005) (11)
In vivo and in vitro effects of glucocorticoids on lymphocyte proliferation in depression (2005) (11)
Exonic variants of the GABA(B) receptor gene and panic disorder. (2000) (11)
Imbalance of the Gs and Gi/o function in post-mortem human brain of depressed patients (2005) (11)
A double-blind comparative multicentre study of controlled-release remoxipride, immediate-release remoxipride and haloperidol in schizophrenia. (1991) (10)
Obstetric complications in distinct schizophrenic subgroups (1993) (10)
The Genetic Heterogeneity of “Schizophrenia” (2000) (10)
Platelet monoamine oxidase in healthy subjects: The “biochemical high-risk paradigm” revisited (1981) (10)
Clinically Relevant Differences in the Therapeutic Profile of Fluperlapine Compared to Haloperidol in the Treatment of Schizophrenic Psychosis - Results of a Multicentre Double-blind Study (1986) (10)
The cholinolytic biperiden in depression (1982) (9)
Consensus on minimal criteria of clinical and neuropathological diagnosis of schizophrenia and affective disorders for post mortem research (1995) (9)
Pre- and postsynaptic alpha-adrenergic effects of clonidine in major depressive disorder. (1988) (9)
Biochemical and Neuropathological Indices for the Aetiology of Schizophrenia (1987) (9)
Neuropathology of the Endogenous Psychoses (2001) (9)
Increased CSF cortisol levels after neuroleptic treatment in schizophrenia (1985) (9)
ARTHROPATHIES AND SCHIZOPHRENIA (1980) (8)
Relationships between platelet and plasma monoamine oxidase, plasma dopamine-beta-hydroxylase, and urinary 3-methoxy-4-hydroxy phenylglycol. (1975) (8)
Magnesium and calcium in the CSF of schizophrenic patients and healthy controls: correlations with cyclic GMP. (1983) (8)
The Concept of Hebephrenia over the Course of Time with Particular Reference to the Wernicke-Kleist-Leonhard School (2002) (8)
Sex differences and distinct subgroups in schizophrenia. A study of 54 chronic hospitalized schizophrenics. (1992) (7)
Urinary phenylethylamine correlates positively with hypomania, and negatively with depression, paranoia, and social introversion on the MMPI (2004) (7)
Early Childhood Catatonia (1999) (7)
Biochemical Membrane Constituents and Activities of Alkaline and Acid Phosphatase and Cathepsin in Cortical and Subcortical Brain Areas in Dementia of the Alzheimer Type (1991) (7)
[Neurotransporters : new aspects of the mechanism of action of psychotropic drugs]. (1993) (7)
The effect of lithium on urinary MHPG in unipolar and bipolar depressed patients (1975) (7)
[An ethological interpretation of stereotypy induced by environmental stimulus (author's transl)]. (1981) (7)
Functional Indices of Biological Disturbance (1983) (7)
Karl Kleist, 1879–1960 (2000) (7)
361. The different genetic background of schizophrenic spectrum psychoses (1998) (7)
Developmental malformations in cerebral structures in "endogenous psychoses" (2002) (6)
Presentation of human neocortical neurons stained with the carbocyanine dye dil compared to the Golgi silver impregnation technique. (1993) (6)
[Current biochemical hypotheses of endogenous depression]. (1985) (6)
The Dopaminergic and Glutamatergic Systems in Schizophrenia (1990) (6)
The AMDP system in international clinical trials: a double-blind comparison of fluperlapine and haloperidol. (1986) (6)
MRI white matter hyperintensity in neuroleptic malignant syndrome (NMS)—a clue to pathogenesis? (2005) (6)
Horizontal two-dimensional electrophoresis of plasma butyrylcholinesterase. (1987) (6)
[Cycloid psychoses as atypical manic-depressive disorders. Results of a family study]. (2006) (5)
Biochemical investigations into the alcoholic delirium: Alterations of biogenic amines (1977) (5)
Clinical investigations into antidepressive mechanisms (1984) (5)
The influence of human corticotropin-releasing hormone on somatostatin secretion in depressed patients and controls (2005) (5)
[Therapy of delirium tremens]. (1978) (5)
Evidence against unusual sex concordance and pseudoautosomal inheritance in the catatonic subtype of schizophrenia (1995) (5)
Absence of a subgroup of chronic schizophrenia in monozygotic twins. Consequences for considerations on the pathogenesis of schizophrenic psychoses (1999) (5)
Association between a null mutation in the human ciliary neurotrophic factor (CNTF) gene and increased incidence of psychiatric diseases? (1996) (4)
[The use and abuse of hypnotics from the viewpoint of the psychiatrist]. (1976) (4)
TEMPORAL LOBE CYTOARCHITECTURAL NEUROPATHOLOGY IN SCHIZOPHRENIA (1992) (4)
P-2-66 Multiple and single dose pharmacokinetics of milnacipran in major depressive patients (1995) (4)
Phenylethylamine and monoamine metabolites in CSF of schizophrenics: Effects of neuroleptic treatment (2005) (4)
3H-spiroperidol binding to peripheral mononuclear cells in schizophrenic and healthy subjects (1993) (4)
Comparative Determination of 3-Methoxy-4-Hydroxyphenylglycol and its Conjugated Derivatives in the Urine of Depressed Patients and Healthy Controls (1986) (4)
The development concept of “endogenous psychoses” (2006) (4)
Distribution of the B33 CTG repeat polymorphism in a subtype of schizophrenia (1998) (4)
Neuroendocrine regulation of growth hormone secretion in major depressive disorder. (1988) (4)
Phenylethylamine and phenylacetic acid in CSF of schizophrenics and healthy controls (1982) (4)
Endocrine parameters and biogenic amines in relationship to psychopathology after cholinergic drug challenge (RS-86) (1988) (4)
Cerebrospinal fluid concentrations of free GABA in schizophrenia: No changes after haloperidol treatment (2005) (4)
Etiology of Endogenous Psychoses (1999) (4)
MAO Inhibition as Antidepressive Mechanism Reevaluated (1983) (3)
Changes in cerebrospinal fluid cyclic nucleotides in alcohol-dependent patients suffering from delirium tremens. (1982) (3)
MAO inhibition as antidepressive mechanism reevaluated. A controlled study with tranylcypromine isomers. (1983) (3)
Triplet repeats in clinical subtypes of schizophrenia: variation at the DRPLA (B 37 CAG repeat) locus is not associated with periodic catatonia Short Communication (1994) (3)
[DL-phenylalanine as an antidepressant. Open study (author's transl)]. (1978) (3)
Growth hormone (GH) secretion following GH-releasing hormone in depression: correlation with clonidine-induced GH release (1988) (3)
[Differential diagnosis, course and outcome of postpartum psychoses. A catamnestic investigation]. (2000) (3)
Morphometry of the entorhinal cortex (1989) (3)
MATERNAL INFECTIOUS ILLNESS AND SCHIZOPHRENIA. AUTHORS' REPLY (1997) (3)
Recent concepts of neuromodulators in affective disorders. (1982) (3)
The Cycloid Psychoses (1999) (3)
The Systematic Schizophrenias (1999) (2)
Interactions of neurotoxins with non-NMDA glutamate receptors: an autoradiographic study. (1994) (2)
The HLA system and schizophrenia (1980) (2)
Investigations of the Cholinergic-Adrenergic Balance in Affective Disorders (1986) (2)
DL-sodium lactate reduces alpha1-adrenergic receptor binding in rat and mouse brain (1985) (2)
Clinical Pictures of Phasic Psychoses (without Cycloid Psychoses) (1999) (2)
HLA-Antigens, Schizophrenia and Brain Atrophy (1980) (2)
ASSOCIATION AND LINKAGE STUDIES IN BIPOLAR AFFECTIVE DISORDER (1992) (2)
Age of Onset, Sex Incidence, Course (1999) (2)
[Therapy of endogenous depression by sleep deprivation. 2. Comparison of psychopathologic and biochemical parameters]. (1974) (2)
HLA, Schizophrenien und Arthropathien (1981) (2)
Maternal infectious illness and schizophrenia. (1997) (2)
[Metabolism of noradrenaline and endogenous depression (author's transl)]. (1980) (2)
Phenelzine in depressed patients. Effects on urinary MHPG excretion in relation to clinical response. (1977) (2)
[Serotonin precursors as antidepressive agents: a review]. (1983) (2)
Quantitative investigations of presenile and senile changes of the human entorhinal region (1990) (2)
Reflection of changes in membrane constituents in various regions of Alzheimer brains to differential scanning thermograms. (1990) (2)
CSF Studies in Schizophrenia: A Multidimensional Approach (1985) (2)
[Manneristic catatonia. A psychotropic drug refractory chronic progressive course]. (1996) (2)
[Schizophrenic psychosis in a patient with Gilles de la Tourette syndrome]. (1988) (2)
Triplet repeats in clinical subtypes of schizophrenia: variation at the DRPLA (B37 CAG repeat) locus is not associated with periodic catatonia (2005) (2)
[The cholinergic-adrenergic equilibrium hypothesis of affective psychoses]. (1988) (2)
[Electroconvulsive therapy in treatment of acute life threatening catatonia in toxic epidermal necrolysis (Lyell syndrome)]. (1992) (2)
The Unsystematic Schizophrenias (1999) (2)
[Biochemical studies in delirium tremens (author's transl)]. (1978) (1)
Erythrocyte acetylcholinesterase in psychiatric disorders and controls (1987) (1)
QUANTITATIVE AUTORADIOGRAPHY OF THE NMDA‐RECEPTOR WITH [3H]MK‐801 AND [3H]GLYCINE IN HUMAN HIPPOCAMPUS (1992) (1)
[Effect of clozapine on the excretion of 3-methoxy-4-hydroxy-phenylglycol, homovanillic acid and 5-hydroxy-indole acetic acid in urine and cerebrospinal fluid]. (1974) (1)
Dopamine D2 -Receptors in Post-mortem Human Brains from Schizophrenic Patients (1990) (1)
Evidence of Reduced Temporolimbic Structure Volumes in Schizophrenia-Reply (1991) (1)
Disulfiram Effect on Depression and Paranoid Score, 5-hydroxyindoleacetic Acid and Vanillylmandelic Acid Excretion in Urine (1971) (1)
[Pregnancy and labor complications--their significance in the development of schizophrenic psychoses]. (1993) (1)
Insulin, Insulin Receptors, and Igf-I Receptors in Post-Mortem Human Brain in Alzheimer’s Disease (1998) (1)
Further Cytoarchitectonic and Quantitative Studies in the Entorhinal Region of Schizophrenics and Normal Controls by Means of a Modified Nissl Technique (1990) (1)
[Clinical signs and management of delirium tremens]. (1981) (1)
9-3 Maternal infectious illness during pregnancy and obstetric complications in different subgroups of schizophrenia (1997) (1)
The reflection of multiple biochemical deficits in nucleus basalis of Meynert of Alzheimer brains to differential scanning thermograms (1989) (1)
Effects of α-lipoic acid on mitochondrial dehydrogenases in cortical regions of post-mortem brain in dementia of Alzheimer type (1993) (1)
Leonhard Classification of Endogenous Psychoses: Cycloid Psychoses, Differentiated Nosology, Differentiated Therapy and Historical Aspects (1991) (1)
9-1 Genetic heterogeneity in schizophrenia: A twin study (1997) (1)
[The histocompatibility system in schizophrenia]. (1982) (1)
[Delirium tremens: unsatisfactory treatment results with dehydrobenzperidol (author's transl)]. (1981) (1)
Brain quinolinic acid in Alzheimer's dementia (1989) (1)
9-5 Genetic heterogeneity in catatonic schizophrenia: A family study (1997) (1)
Double-blind comparison of remoxipride and haloperidol in acute treatment of schizophrenia: gender differences, clinical efficacy and extrapyramidal symptoms (1991) (0)
S-31-3 Refractory depression: First line treatment (1996) (0)
Editorial Board (2005) (0)
Morphological Disturbances in the Brains of Schizophrenics (1991) (0)
THE GROWTH HORMONE-RELEASING HORMONE (GHRH)-TEST IN DEPRESSION AND OTHER PSYCHIATRIC DISORDERS. CLINICAL SIGNIFICANCE AND PATHOPHYSIOLOGIC IMPLICATIONS (1992) (0)
A Nosological Concept Beside DSM and ICD (1997) (0)
ADENOSINE RECEPTOR ANTGONISTS: INTERACTION WITH ADENOSINE A1 RECEPTORS IN HUMAN HIPPOCAMPUS (1992) (0)
W12.04 Motility psychosis: A functional disease of the psychomotor sphere (2000) (0)
Editorial Board (2006) (0)
General remarks on twin origination (1999) (0)
Editorial Board (2004) (0)
Progressive supranuclear palsy misdiagnosed as depression and catatonic schizophrenia (2007) (0)
[Remarks on the contribution of D. Sigmund. Cycloid psychosis and empirical-statistical research. Nervenarzt (1998) 69:228-37]. (1999) (0)
Letter from the editors (1993) (0)
DISTRIBUTION OF [3H]‐KAINATE BINDING SITES IN HUMAN BRAIN (1992) (0)
Editorial Board (2004) (0)
Schizophrenia is a Genetically Heterogenous Disease (1997) (0)
[Different urinary excretion of 3-methoxy-4-hydroxyphenyl-glycol and response to tricyclic antidepressive drugs]. (1974) (0)
H-Spiroperidol Binding to Peripheral Mononuclear Cells in Schizophrenic and Healthy Subjects (2002) (0)
Epidemiological aspects of obsessive-compulsive disorder (1992) (0)
Editorial Board (2004) (0)
Editorial Board (2004) (0)
Erratum to “confirmation of reduced temporal limbic structure volume on magnetic resonance imaging in male patients with schizophrenia” [Psychiatry Res. Neuroimaging 67 (1996) 135–143] (1997) (0)
The Question of Endogenous Mixed Psychosis (1999) (0)
HIPPOCAMPAL VOLUME DEFICIT ON MRI IN YOUNG MALE SCHIZOPHRENIC PATIENTS (1992) (0)
1308 – INFLUENCE OF PSYCHOTROPIC DRUGS ON NOREPINEPHRINE METABOLISM IN CNS OF DEPRESSED PATIENTS (1977) (0)
Psychoses of the schizophrenic spectrum in twins : a discussion of the nature-nurture debate in the etiology of "endogenous" psychoses (1999) (0)
Promoter polymorphisms of the 5-HT2C receptor gene: Association study with panic disorder in two independent samples (2000) (0)
Announcements of the German Society of Biological Psychatry (Deutsche Gesellschaft für Biologische Psychiatrie DGBP) (1999) (0)
Editorial Board (2006) (0)
Editorial Board (2005) (0)
Measurement of Neuro-Transmitter Metabolites in Blood, Urine and CSF in Psychiatric Patients (1979) (0)
Editorial Board (2005) (0)
Pathobiochemical Aspects of Parkinson’s Disease and Dementia of Alzheimer Type (1990) (0)
DIHYDROPYRIDINE CALCIUM CHANNEL ANTAGONISTS: INTERACTION WITH ADENOSINE UPTAKE SITES IN HUMAN BRAIN. (1992) (0)
[Hypochondriacal euphoria as a special form of monopolar affective psychosis]. (2001) (0)
Abstracts Second Congress of the European Society for Clinical Neuropharmacology (1995) (0)
Quantitative investigations in thick frozen sections stained with Gallyas' silver impregnation for the demonstration of Alzheimer changes (1989) (0)
News items (2004) (0)
Editorial Board (2004) (0)
Monoamine oxidase and its selective inhibitors. Satellite symposium of the International Brain Research Organization, Mannheim, March 29-30, 1982. (1983) (0)
THE NOSOLOGICAL DIFFERENTIATION OF CATATONIA (2004) (0)
Editorial Board (2006) (0)
[HLA, schizophrenias and arthropathies]. (1981) (0)
The different genetic background of schizophrenic subgroups (1998) (0)
Reflection of central aminergic-cholinergic imbalance by peripheral enzymes in psychiatric disorders? (1988) (0)
Editorial Board (2005) (0)
The twins method in research (1999) (0)
The new generation of selective monoamine oxidase-inhibitors: biochemical, pharmacological and clinical perspectives. (1988) (0)
Methodology of a systematic twin study (1999) (0)
Title Page / Contents / Preface / List of Abbreviations (1983) (0)
Polymorphic monoamine oxidase a and 5-HT-transporter genes: Analysis of interactions with panic disorder (2000) (0)
Differential disturbances of neurotransmission in depression (1986) (0)
["Accentuated disposition"--rediscovery of an important concept in personality psychology]. (2002) (0)
Editorial Board (2006) (0)
S-30-3 Temporal lobe cytoarchitectural pathology in schizophrenia (1996) (0)
Obstetrie complications in distinct schizophrenie subgroups (2013) (0)
[Schizophrenia and birth seasonality--contrary results in relation to genetic risk]. (1993) (0)
Volumetry of Limbic Structures in Schizophrenics and Controls (1993) (0)
Editorial Board (2005) (0)
[HLA-system in psychiatric research (author's transl)]. (1981) (0)
The neuropathology of schizophrenia. (1988) (0)
AUTORADIOGRAPHIC DISTRIBUTION OF THE QUISQUALATE RECEPTOR IN HUMAN HIPPOCAMPUS (1992) (0)
Differentielle Störungen der Neurotransmission bei Depressionen (1985) (0)
Postdexamethasone cortisol 7 am/4 pm ratio : a state variable in depression ? (1991) (0)
387. Is the genetics of schizophrenia and bipolar disorder the genetics of neurodevelopment? Focus on transcriptional regulator genes (2000) (0)
[The early childhood form of negativistic catatonia]. (1993) (0)
Why should the Psychiatrist be Interested in Neurochemistry (1985) (0)
Contents, Vol. 23, 1990 (1990) (0)
Contents, Vol. 23, 1990 (1990) (0)
[Psychotropic drugs as tools for clinical research into schizophrenia (author's transl)]. (1978) (0)
Differential effects of neuromelanin and synthetic dopamine melanin on cell lines Inaugural – (2005) (0)

This paper list is powered by the following services:

Helmut Beckmann's Academic­Influence.com Rankings

Why Is Helmut Beckmann Influential?

Helmut Beckmann's Published Works

Published Works

Helmut Beckmann's AcademicInfluence.com Rankings